Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children (EPIPOP)
Primary Purpose
Cardiovascular Diseases, Arteriosclerosis, Atherosclerosis
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
pOpmètre®
Sphygmocor
Sponsored by
About this trial
This is an interventional diagnostic trial for Cardiovascular Diseases focused on measuring Arterial stiffness, pulse wave velocity, Sphygmocor, applanation tonometry, pOpmètre, children, EPIPAGE cohort
Eligibility Criteria
Inclusion Criteria:
- children between 4 and 8 years old hospitalized in the Mother and Children Hospital in Nantes during the study period.
Exclusion Criteria:
- Vasoconstrictor treatment,
- compressive bandage on the measured area,
- peripheral venous access on the measured side,
- vascular surgery or pathology on the measured area,
- significant pain or agitation,
- parental or legal representative disapproval,
- child disapproval.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
SphygmoCor®
pOpmètre®
Arm Description
Outcomes
Primary Outcome Measures
Difference between the two simultaneous measurements of velocity of the pulse wave by the pOpmeter® and the Sphygmocor®.
Secondary Outcome Measures
Full Information
NCT ID
NCT02991703
First Posted
November 23, 2016
Last Updated
December 9, 2016
Sponsor
Nantes University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT02991703
Brief Title
Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children
Acronym
EPIPOP
Study Type
Interventional
2. Study Status
Record Verification Date
December 2016
Overall Recruitment Status
Unknown status
Study Start Date
December 2016 (undefined)
Primary Completion Date
November 2017 (Anticipated)
Study Completion Date
November 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Nantes University Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Arterial stiffness is an important marker of cardiovascular risk. It is measured by pulse wave velocity. The reference device to measure pulse wave velocity is the Sphygmocor which uses applanation tonometry. It is used in adults and children. An easier method called pOpmètre using saturation sensors is validated in adults but not in children. The objective of this study is to compare the pulse wave velocity values measured with the pOpmètre® with those of the SphygmoCor® to validate the pOpmètre in children between 4 and 8 years old.
Detailed Description
Prematurity is associated with an increased risk of developing cardio-vascular diseases in adulthood : a low birth weight linked to prematurity is correlated to a higher coronary disease mortality rate, a higher blood pressure level in adulthood, to abnormal glucose metabolism regulation, and to signs of nephron reduction. An independent marker of cardiovascular risk is arterial stiffness: it is associated with a higher risk of major cardiovascular events including stroke, acute coronary syndrome and complications of end-stage renal disease. It is measured by pulse wave velocity which is the gold standard in adulthood. Pulse wave velocity is also correlated to cardiovascular risk in childhood. National cohort EPIPAGE II is made of 4290 premature babies born in 2011. A study is scheduled at 5 years old and a half including a medical examination and a neuropsychological evaluation. An ancillary study lengthening medical consultation for 15 minutes is scheduled with 750 to 1000 of these children for a more precise vascular evaluation including pulse wave velocity. Different methods can be used to measure pulse wave velocity in children: these include applanation tonometry devices such as the SphygmoCor ® system. Its reference values are well known in adulthood and were determined more recently in childhood. It is the reference device but it is expensive, can be used only in expert health centres and time of measurement is long. In children, an easier-to-use and faster device would be more advantageous. The pOpmètre® uses 2 distal oxygen saturation sensors on finger and toe to deduce pulse wave velocity. This device has already been validated in adults. The aim of this study is to validate the pOpmètre in children between 4 and 8 years old. In that purpose, patients are installed in the supine position, at rest. The child's mensurations are measured. The two pOpmètre sensors are put on finger and toe. Blood pressure is measured by an armband on the right limb. Then another armband is put around the thigh and a tonometer is applied on the right carotid which allows pulse wave velocity measuring by the Sphygmocor. Pulse wave velocity is measured with the pOpmètre using the time delay between finger pulse signal and toe pulse signal. The values got with the two devices are compared using a Bland and Altman graph. The pOpmètre is considered to be validated if the 95% confidence interval of the bias is included between -0.5 m/sec and 0.5 m/sec that is about 10% of the normal value at that age (5.0 m/s +/-0.13).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Diseases, Arteriosclerosis, Atherosclerosis
Keywords
Arterial stiffness, pulse wave velocity, Sphygmocor, applanation tonometry, pOpmètre, children, EPIPAGE cohort
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
SphygmoCor®
Arm Type
Active Comparator
Arm Title
pOpmètre®
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
pOpmètre®
Intervention Description
the pOpmètre® uses saturation sensors,
Intervention Type
Device
Intervention Name(s)
Sphygmocor
Intervention Description
the Sphygmocor uses applanation tonometry
Primary Outcome Measure Information:
Title
Difference between the two simultaneous measurements of velocity of the pulse wave by the pOpmeter® and the Sphygmocor®.
Time Frame
Day One
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
8 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
children between 4 and 8 years old hospitalized in the Mother and Children Hospital in Nantes during the study period.
Exclusion Criteria:
Vasoconstrictor treatment,
compressive bandage on the measured area,
peripheral venous access on the measured side,
vascular surgery or pathology on the measured area,
significant pain or agitation,
parental or legal representative disapproval,
child disapproval.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jean-Christophe ROZE, Pr
Email
jeanchristophe.roze@chu-nantes.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Emma Allain-Launay, Dr
Phone
02 40 08 36 60
Email
emma.allainlaunay@chu-nantes.fr
12. IPD Sharing Statement
Citations:
PubMed Identifier
16461839
Citation
Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation. 2006 Feb 7;113(5):664-70. doi: 10.1161/CIRCULATIONAHA.105.579342.
Results Reference
background
PubMed Identifier
19729599
Citation
Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, Jacobson M, Mahoney L, Mietus-Snyder M, Rocchini A, Steinberger J, McCrindle B; American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension. 2009 Nov;54(5):919-50. doi: 10.1161/HYPERTENSIONAHA.109.192639. Epub 2009 Sep 3. Erratum In: Hypertension. 2010 Sep;56(3):e36.
Results Reference
background
PubMed Identifier
24716860
Citation
Ancel PY, Goffinet F; EPIPAGE 2 Writing Group. EPIPAGE 2: a preterm birth cohort in France in 2011. BMC Pediatr. 2014 Apr 9;14:97. doi: 10.1186/1471-2431-14-97.
Results Reference
background
PubMed Identifier
20530030
Citation
Reference Values for Arterial Stiffness' Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: 'establishing normal and reference values'. Eur Heart J. 2010 Oct;31(19):2338-50. doi: 10.1093/eurheartj/ehq165. Epub 2010 Jun 7.
Results Reference
background
PubMed Identifier
20566959
Citation
Reusz GS, Cseprekal O, Temmar M, Kis E, Cherif AB, Thaleb A, Fekete A, Szabo AJ, Benetos A, Salvi P. Reference values of pulse wave velocity in healthy children and teenagers. Hypertension. 2010 Aug;56(2):217-24. doi: 10.1161/HYPERTENSIONAHA.110.152686. Epub 2010 Jun 21.
Results Reference
background
PubMed Identifier
26989504
Citation
Curcio S, Garcia-Espinosa V, Arana M, Farro I, Chiesa P, Giachetto G, Zocalo Y, Bia D. Growing-Related Changes in Arterial Properties of Healthy Children, Adolescents, and Young Adults Nonexposed to Cardiovascular Risk Factors: Analysis of Gender-Related Differences. Int J Hypertens. 2016;2016:4982676. doi: 10.1155/2016/4982676. Epub 2016 Feb 18.
Results Reference
background
PubMed Identifier
25682547
Citation
Alivon M, Vo-Duc Phuong T, Vignon V, Bozec E, Khettab H, Hanon O, Briet M, Halimi JM, Hallab M, Plichart M, Mohammedi K, Marre M, Boutouyrie P, Laurent S. A novel device for measuring arterial stiffness using finger-toe pulse wave velocity: Validation study of the pOpmetre(R). Arch Cardiovasc Dis. 2015 Apr;108(4):227-34. doi: 10.1016/j.acvd.2014.12.003. Epub 2015 Feb 11.
Results Reference
background
PubMed Identifier
32218581
Citation
Bichali S, Bruel A, Boivin M, Roussey G, Romefort B, Roze JC, Allain-Launay E. Simplified pulse wave velocity measurement in children: Is the pOpmetre valid? PLoS One. 2020 Mar 27;15(3):e0230817. doi: 10.1371/journal.pone.0230817. eCollection 2020.
Results Reference
derived
Links:
URL
https://www.youtube.com/watch?v=4aFnQ_0_bOI
Description
Related Info
URL
http://www.axelife.fr/fr/index.php
Description
Related Info
Learn more about this trial
Simplified Pulse Wave Velocity Measurement, Validation Study of the pOpmètre in Children
We'll reach out to this number within 24 hrs